prikaz prve stranice dokumenta Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
  Preuzmi
PDF 882.52 KB
Stručni rad - Pismo uredniku
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Leukemia Research, 119 (2022); 106905. https://doi.org/10.1016/j.leukres.2022.106905
Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljic, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Krečak, I., Sorić, E., Sabljic, A., Galušić, D., Holik, H. ... Kušec, R. (2022). Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research, 119.. doi: 10.1016/j.leukres.2022.106905

Lucijanić, Marko, et al. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research, vol. 119, 2022. https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Anica Sabljic, Davor Galušić, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović i Rajko Kušec. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research 119 (2022). https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, M., et al. (2022) 'Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis', Leukemia Research, 119. doi: 10.1016/j.leukres.2022.106905

Lucijanić M, Krečak I, Sorić E, Sabljic A, Galušić D, Holik H, i sur.. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research [Internet]. 08.2022. [pristupljeno 29.11.2024.];119. doi: 10.1016/j.leukres.2022.106905

M. Lucijanić, et al., "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis", Leukemia Research, vol. 119, Kolovoz 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:524953. [Citirano: 29.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:524953
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
AutorMarko Lucijanić
AutorIvan Krečak
AutorEna Sorić
AutorAnica Sabljic
AutorDavor Galušić
AutorHrvoje Holik
AutorVlatka Periša
AutorMartina Morić Perić
AutorIvan Zekanović
AutorRajko Kušec
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Pismo uredniku
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaLeukemia Research
Brojčani podacivol. 119, 106905
p-ISSN0145-2126
DOIhttps://doi.org/10.1016/j.leukres.2022.106905
URN:NBNurn:nbn:hr:105:524953
Datum objave publikacije2022-08
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S014521262200131X
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Datum isteka embarga: 2023-09-01
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-12-29 10:44:20